Last reviewed · How we verify

Prevention of influenza caused by virus subtypes A and B contained in the vaccine — Treatment Landscape & Competitive Intelligence

Prevention of influenza caused by virus subtypes A and B contained in the vaccine (disease) competitive landscape: 1 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

1 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Prevention of influenza caused by virus subtypes A and B contained in the vaccine, deduplicated by molecule. See the full disease page for line-of-therapy detail.

DrugGenericSponsorClassTargetLine of therapyFirst approval
Flu Vaccine Flu Vaccine La Fundacion Favaloro para la Investigacion y la Docencia Medica Prophylactic vaccine Influenza A and B viral hemagglutinin and neuraminidase surface antigens

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

  1. La Fundacion Favaloro para la Investigacion y la Docencia Medica · 1 drug in Prevention of influenza caused by virus subtypes A and B contained in the vaccine

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Prevention of influenza caused by virus subtypes A and B contained in the vaccine:

Cite this brief

Drug Landscape (2026). Prevention of influenza caused by virus subtypes A and B contained in the vaccine — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/prevention-of-influenza-caused-by-virus-subtypes-a-and-b-contained-in-the-vaccine. Accessed 2026-06-10.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing